ARAKIS
Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company's research capability specializes in the cytokine and receptor mediated mechanisms of disease. The company identifies, develops, and commercializes product opportunities based upon new clinical uses for known drugs or known drug templates, as well as termed performance enhanced medicines.
ARAKIS
Industry:
Biotechnology Health Care Oncology Pharmaceutical
Founded:
2000-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.arakis.com
Total Employee:
51+
Status:
Active
Contact:
+44 20 7691 2081
Total Funding:
49 M GBP
Technology used in webpage:
SPF QuickPacket
Similar Organizations
AEterna Zentaris
AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Inthera Bioscience
Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
TargImmune Therapeutics
TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.
Current Employees Featured
Founder
Investors List
Novo Holdings
Novo Holdings investment in Series C - Arakis
Scottish Equity Partners
Scottish Equity Partners investment in Series C - Arakis
Excalibur Fund Managers
Excalibur Fund Managers investment in Series B - Arakis
3i Group
3i Group investment in Series B - Arakis
Nomura International
Nomura International investment in Series B - Arakis
Alice Ventures
Alice Ventures investment in Series B - Arakis
Excalibur Fund Managers
Excalibur Fund Managers investment in Venture Round - Arakis
Alice Ventures
Alice Ventures investment in Venture Round - Arakis
Official Site Inspections
http://www.arakis.com
- Host name: 64-187-239-229.quickpacket.com
- IP address: 64.187.239.229
- Location: West Chicago United States
- Latitude: 41.8879
- Longitude: -88.1995
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60185
More informations about "Arakis"
Arakis - Crunchbase Company Profile & Funding
Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company's research capability specializes in the cytokine and receptor …See details»
Arakis - Crunchbase Company Profile & Funding
At Arakis, we are building an innovative travel platform that empowers travelers to earn money while exploring the world. Our vision is to create a community-driven ecosystem where travel …See details»
Arakis Company Profile 2024: Valuation, Investors, …
When was Arakis founded? Arakis was founded in 2000. Where is Arakis headquartered? Arakis is headquartered in Saffron Walden, United Kingdom. …See details»
Arakis - Products, Competitors, Financials, Employees, …
Arakis is a private UK based biopharmaceutical company that discovers, develops and commercializes medicinal products based on established drugs and drug templates. Use the …See details»
Arakis - Crunchbase Company Profile & Funding
Arakis they can provide you with solutions based on the wants and issues since they are available and attentive. To enhance the beauty of both today and tomorrow technologies, they are …See details»
Arakis Ltd - Saffron Walden, United Kingdom - bionity.com
Nov 2, 2005 Arakis Ltd. , a wholly-owned subsidiary of Sosei Co. Ltd. , and Vectura Group plc announced that their collaborative product, NVA237 (formerly AD 237), a ... Read news . 07 …See details»
Arakis - LinkedIn
Arakis | 3,694 followers on LinkedIn. Explore, and earn with Arakis – the pioneering, decentralized travel platform that shares revenue. ️🌍🌴 | Arakis is the travel ecosystem of the future.See details»
Arakis Energy Corp - Company Profile and News - Bloomberg …
Company profile page for Arakis Energy Corp including stock price, company news, executives, board members, and contact informationSee details»
Revolting Against Corporations: The Arakis Plan for a
May 23, 2023 Arakis believes that the power of decision-making in the tourism industry should be in the hands of the people, not the corporations. Arakis is committed to giving power back …See details»
THE ARAKIS PERIOD: 1992-98 - Human Rights Watch
In July 1993, Arakis announced that it would assume full ownership over the project—buying out its partner State Petroleum —and concentrate on raising the estimated U.S. $ 750 million to $1 ...See details»
Canadian stock promoter Alexander barred again | Reuters
A Canadian stock promoter at the center of the tumultuous rise and fall of Arakis Energy Corp in the 1990s has again been slapped with a securities ban, regulators said on Wednesday.See details»
Arakis - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... Apr 26, 2002: Series B - Arakis . 4: …See details»
Arakis - YouTube
Arakis is a decentralized travel ecosystem of the future that empowers travellers to earn money when exploring the world. Arakis is a decentralized travel ecosystem of the future that …See details»
Arakis is a revolution in the crypto space… but what is Arakis??
Arakis is a revolution in the crypto space… but what is Arakis?? Arakis will transform the way we travel by using the power of Blockchain and RST (Revenue Sharing Token). Arakis is a ...See details»
Amgen and Arrakis Therapeutics Announce Multi-Target …
Collaboration Creates “Targeted RNA Degraders” by Bringing Together Amgen’s Induced Proximity Platform Discovery Expertise and Arrakis’ Leading-edge RNA-targeted Drug …See details»
Exploring the Promise of @Arakis: Shaping the Future of ... - Medium
🚀 Exploring the Promise of @Arakis: Shaping the Future of blockchain tech. In the fast-paced world of blockchain technology, @Arakis has emerged as a shining star, poised to redefine the …See details»
Arrakis - Arrakis Therapeutics
This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that …See details»
Introducing Arakis: Your Gateway to Investing in the Travel Industry
This same Hilton Hotel will be listed on the Arakis Travel App (more information on the travel app will be out soon!) for users to book rooms in, just like a traditional booking platform. Assuming …See details»
Arrakis Therapeutics - Crunchbase Company Profile & Funding
Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce …See details»
ARAKII
Subscribe to get early access to our drops - and exclusive offers such as future archive sales only for subscribersSee details»